We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

University Hospitals Offers the Following Cell Therapy Clinical Trials

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print
May 2018

 

CASE2Z16: Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
P.I.: Folashade Otegbeye, MD
Clinicaltrials.gov #NCT02890758

CASE2417: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
P.I.: Paolo Caimi, MD
Clinicaltrials.gov #NCT03434769

CASE 1Z14: Intra-Osseous Co-Transplant of Cord Blood and Mesenchymal Stomal Cells: A Feasibility Study
P.I.: Leland Metheny, MD
Clinicaltrials.gov #NCT02181478

CASE 6307: O6-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients with MGMT Positive Tumors with Infusion of Autologous P140KMGMT+Hematopoietic Progenitors to Protect Hematopoiesis
P.I.: Stan Gerson, MD
Clinicaltrials.gov #NCT01269424

CASE 3113: Pilot Trial of a Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients with Metastatic Breast Cancer
P.I.: Joseph Baar, MD
Clinicaltrials.gov #NCT02479230

BMT CTN 1401: Personalized DC vaccine for multiple myeloma
P.I.: Ehsan Malek, MD
ClinicalTrials.gov Identifier: NCT02728102

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print